British healthtech company Huma Therapeutics has initiated the global launch of Hi Scribe, a generative AI (genAI) clinical documentation tool designed to automate and streamline the creation of clinical notes.
Powered by over 60 million consultations conducted by eConsult, which Huma acquired last year, Hi Scribe is available through the Huma Cloud Platform (HCP), providing real time clinical documentation automation and the generation of structured clinical notes that can be directly integrated into electronic health record (EHR) systems.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Hi Scribe is already launched in the UK to 870 practices, covering around 10 million patients, with write-back and coding capabilities for the EHR systems EMIS and SystmOne.
Now rolling out across more than 4,500 health systems and clinics powered by Huma technologies, worldwide, Huma CEO and founder Dan Vahdat stated that administrative burdens such as process compliance and accurate billing remain some of the “greatest challenges” facing healthcare systems globally.
“Hi Scribe gives clinicians critical time back, allowing them to focus on what matters most: their patients,” said Vahdat.
Initiation of the tool’s global launch follows the UK’s National Health Service (NHS) England guidance around using AI-enabled scribing products in healthcare settings that was issued in April.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataRelating to best practices surrounding controls and implementation, the NHS guidelines advise healthcare systems to integrate such AI products with their principal EHR system and to ensure legal and regulatory requirements are factored into the procurement and implementation of their chosen products.
Dr Murray Ellender, head of UK Healthcare at Huma commented: “By leveraging genAI with strong regulatory governance, we are ensuring safe, effective, and efficient care. We are excited in the near future to start helping care providers with intelligent suggestions for next steps — ensuring that nothing is left unnoticed.”
Huma recently announced a partnership with growth equity company Eckuity to support its development of technology infrastructure to support ongoing plans to acquire companies and launch digital solutions across the healthcare space.
